ID

28486

Description

Effect of Abrupt Plavix® Discontinuation on Platelet Function; ODM derived from: https://clinicaltrials.gov/show/NCT00670943

Link

https://clinicaltrials.gov/show/NCT00670943

Keywords

Versions (1)
  1. 1/17/18 1/17/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 17, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Artery Disease NCT00670943

English

Eligibility Coronary Artery Disease NCT00670943

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
group 1: patients suffering from stable cad scheduled to discontinue clopidogrel therapy at least one month after stent implantation
Description

Coronary Artery Disease Stable | Clopidogrel To be stopped | Placement of stent

Data type

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0070166
UMLS CUI [2,2]
C1272691
UMLS CUI [3]
C0522776
group 2: stable clopidogrel-naïve cad patients
Description

Coronary Artery Disease Stable | Clopidogrel naive

Data type

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0070166
UMLS CUI [2,2]
C0919936
patients willing to participate in the study and to sign the informed consent form
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
Description

Acute Coronary Syndrome | Revascularization

Data type

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0581603
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), ticlopidine, dipyridamole, warfarin or acenocoumarol
Description

Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol

Data type

boolean

Alias
UMLS CUI [1]
C0003211
UMLS CUI [2]
C1257954
UMLS CUI [3]
C0040207
UMLS CUI [4]
C0012582
UMLS CUI [5]
C0043031
UMLS CUI [6]
C0000956
major surgical procedure within 1 month before enrolment
Description

Major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
platelet count outside the 100 000 to 450 000/μl range
Description

Platelet count abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0580317
hematocrit < 25% or haemoglobin < 100 g/l
Description

Hematocrit procedure | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0018935
UMLS CUI [2]
C0518015
patient undergoing dialysis for chronic renal failure
Description

Dialysis Chronic Kidney Failure

Data type

boolean

Alias
UMLS CUI [1,1]
C0011946
UMLS CUI [1,2]
C0022661
Back to the top of the page

Similar models

Eligibility Coronary Artery Disease NCT00670943

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Coronary Artery Disease Stable | Clopidogrel To be stopped | Placement of stent
Item
group 1: patients suffering from stable cad scheduled to discontinue clopidogrel therapy at least one month after stent implantation
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C0522776 (UMLS CUI [3])
Coronary Artery Disease Stable | Clopidogrel naive
Item
group 2: stable clopidogrel-naïve cad patients
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
Informed Consent
Item
patients willing to participate in the study and to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acute Coronary Syndrome | Revascularization
Item
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
boolean
C0948089 (UMLS CUI [1])
C0581603 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol
Item
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), ticlopidine, dipyridamole, warfarin or acenocoumarol
boolean
C0003211 (UMLS CUI [1])
C1257954 (UMLS CUI [2])
C0040207 (UMLS CUI [3])
C0012582 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
C0000956 (UMLS CUI [6])
Major surgery
Item
major surgical procedure within 1 month before enrolment
boolean
C0679637 (UMLS CUI [1])
Platelet count abnormal
Item
platelet count outside the 100 000 to 450 000/μl range
boolean
C0580317 (UMLS CUI [1])
Hematocrit procedure | Hemoglobin measurement
Item
hematocrit < 25% or haemoglobin < 100 g/l
boolean
C0018935 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
Dialysis Chronic Kidney Failure
Item
patient undergoing dialysis for chronic renal failure
boolean
C0011946 (UMLS CUI [1,1])
C0022661 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial